After a summer hiatus, @23aloha and I are thrilled to return with the ongoing Biotech Tweets of the Week feature. Each edition features the top story-lines, analysis and discussion from the world of biotech, pharma, drug development, and healthcare.
This week's edition features:
Biotech Tweets of the Week (September 12-16, 2016)
This week's edition features:
- Celgene releases IBD "data" $CELG
- Sarepta takes a wild ride on something, everything, or nothing $SRPT
- Spectrum and Dr. Raj take their medicine at FDA panel $SPPI
- Aerie Pharma cashes in on positive glaucoma data $AERI
- Novavax plunges after RSV trial fails $NVAX
- The "Start Here" conversation of the week, and
- As Seen on the Stream: the best of the rest, including $AGN $AGTC $AMRN $ARLZ $BLUE $CRBP $GERN $GILD $GLPG $HZNP $RNVC $RPTP $TSRO $VRTX $VTAE $XBI $IBB
Biotech Tweets of the Week (September 12-16, 2016)
RSS Feed
